Abiopharma

🔍 Sparling Ian (Executive)

Company: WIDEPOINT CORP (WYY)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Sold 77,577 shares of Common Stock at $14.72 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 93,849.00 | transaction_form_type: 4
• Sold 34,923 shares of Common Stock at $17.52 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 58,926.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 42,949 shares of Common Stock at $19.5 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 15,977.00 | transaction_form_type: 4
• Holds 9,714 shares of Stock Option (right to buy) at $1.82 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2028-08-04 | shares_owned_after: 9,714.00 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.37 to $17.63, inclusive. The Reporting Person undertakes to provide WidePoint Corporation (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F2: The stock options were granted pursuant to the issuer's Amended and Restated 2008 Stock Incentive Plan and will vest in full at the third anniversary of the date of grant.